December 13 (SeeNews) - The European Commission said on Friday it has approved, under EU state aid rules, a Slovenian scheme of some 52 million euro ($54.5 million) to support Lek Pharmaceuticals, owned by Switzerland's Sandoz, in the construction of a new high-tech plant for biological drug substances.